Inhaled iloprost as third add-on therapy in idiopathic pulmonary arterial hypertension

Triple combination therapy is suggested in current pulmonary arterial hypertension guidelines in case of unsatisfactory treatment with oral double combination therapy. However, there is a lack of evidence concerning some of the drug combinations currently employed. We demonstrate the clinical and he...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandes, Caio J.C.S., da Silva, Taysa A.F., Alves Jr, Jose L., Jardim, Carlos V.P., de Souza, Rogerio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829527/
https://www.ncbi.nlm.nih.gov/pubmed/33532056
http://dx.doi.org/10.1177/2045894020981350
_version_ 1783641187957080064
author Fernandes, Caio J.C.S.
da Silva, Taysa A.F.
Alves Jr, Jose L.
Jardim, Carlos V.P.
de Souza, Rogerio
author_facet Fernandes, Caio J.C.S.
da Silva, Taysa A.F.
Alves Jr, Jose L.
Jardim, Carlos V.P.
de Souza, Rogerio
author_sort Fernandes, Caio J.C.S.
collection PubMed
description Triple combination therapy is suggested in current pulmonary arterial hypertension guidelines in case of unsatisfactory treatment with oral double combination therapy. However, there is a lack of evidence concerning some of the drug combinations currently employed. We demonstrate the clinical and hemodynamical benefits of inhaled iloprost as third add-on therapy in idiopathic pulmonary arterial hypertension.
format Online
Article
Text
id pubmed-7829527
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-78295272021-02-01 Inhaled iloprost as third add-on therapy in idiopathic pulmonary arterial hypertension Fernandes, Caio J.C.S. da Silva, Taysa A.F. Alves Jr, Jose L. Jardim, Carlos V.P. de Souza, Rogerio Pulm Circ Research Letter Triple combination therapy is suggested in current pulmonary arterial hypertension guidelines in case of unsatisfactory treatment with oral double combination therapy. However, there is a lack of evidence concerning some of the drug combinations currently employed. We demonstrate the clinical and hemodynamical benefits of inhaled iloprost as third add-on therapy in idiopathic pulmonary arterial hypertension. SAGE Publications 2021-01-20 /pmc/articles/PMC7829527/ /pubmed/33532056 http://dx.doi.org/10.1177/2045894020981350 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Research Letter
Fernandes, Caio J.C.S.
da Silva, Taysa A.F.
Alves Jr, Jose L.
Jardim, Carlos V.P.
de Souza, Rogerio
Inhaled iloprost as third add-on therapy in idiopathic pulmonary arterial hypertension
title Inhaled iloprost as third add-on therapy in idiopathic pulmonary arterial hypertension
title_full Inhaled iloprost as third add-on therapy in idiopathic pulmonary arterial hypertension
title_fullStr Inhaled iloprost as third add-on therapy in idiopathic pulmonary arterial hypertension
title_full_unstemmed Inhaled iloprost as third add-on therapy in idiopathic pulmonary arterial hypertension
title_short Inhaled iloprost as third add-on therapy in idiopathic pulmonary arterial hypertension
title_sort inhaled iloprost as third add-on therapy in idiopathic pulmonary arterial hypertension
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829527/
https://www.ncbi.nlm.nih.gov/pubmed/33532056
http://dx.doi.org/10.1177/2045894020981350
work_keys_str_mv AT fernandescaiojcs inhalediloprostasthirdaddontherapyinidiopathicpulmonaryarterialhypertension
AT dasilvataysaaf inhalediloprostasthirdaddontherapyinidiopathicpulmonaryarterialhypertension
AT alvesjrjosel inhalediloprostasthirdaddontherapyinidiopathicpulmonaryarterialhypertension
AT jardimcarlosvp inhalediloprostasthirdaddontherapyinidiopathicpulmonaryarterialhypertension
AT desouzarogerio inhalediloprostasthirdaddontherapyinidiopathicpulmonaryarterialhypertension

Ejemplares similares